An Overview on Pharmaceutical Supply Chain: A Next Step towards Good Manufacturing Practice

Volume 1 - Issue 2

Kapoor D¹*, Vyas RB¹ and Dadarwal D²

Received: March 23, 2018;   Published: March 29, 2018

DOI: 10.32474/DDIPIJ.2018.01.000107

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

The top priority in any health system is delivering of medicine as a strategic product. In the present context of a health-conscious society, management of pharmaceutical supply chains has become more complex because it involves the life-saving interest of human being and requires the participation of different stakeholders such as pharmaceutical manufacturers, wholesalers, distributors, customers, information service providers and regulatory agencies. Limited research is available in the area of pharmaceutical supply chains. Pharmaceutical companies, a most important player of the drug supply chain, are subject to many risks. These risks interrupt the quantity and quality of supply of medicine and their delivery to the accurate place and customers and at the correct time.

Keywords: Drug Counterfeiting; Temperature Controlled Logistics; Supplier Qualification; Performance Management; Globalization; Sustainability

Abbrevations: OTC: Over the Counter; CDSCO: Central Drug Standards and Control Organization; NPPA: National Pharmaceutical Pricing Authority; RFID:Radio Frequency Identification Technology; EPC: Electronic Product Code; EPC: Electronic Product Code

Abstract| Introduction| Benefits of Supply Chain Management| Drug Counterfeiting| Standard Operating Procedure for Supplier Qualification (SOP)| Conclusion| References|